Current and emerging pharmacotherapy for the treatment of adult attention deficit hyperactivity disorder (ADHD)
Current and emerging pharmacotherapy for the treatment of adult attention deficit hyperactivity disorder (ADHD) is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Current and emerging pharmacotherapy for the treatment of adult attention deficit hyperactivity disorder (ADHD) have?
Current and emerging pharmacotherapy for the treatment of adult attention deficit hyperactivity disorder (ADHD) has 32 citations in the OpenAlex counts ScholarIQ stores.
When was Current and emerging pharmacotherapy for the treatment of adult attention deficit hyperactivity disorder (ADHD) published?
Current and emerging pharmacotherapy for the treatment of adult attention deficit hyperactivity disorder (ADHD) has 2019 year in the ScholarIQ index.
What is the open-access status of Current and emerging pharmacotherapy for the treatment of adult attention deficit hyperactivity disorder (ADHD)?
Current and emerging pharmacotherapy for the treatment of adult attention deficit hyperactivity disorder (ADHD) has closed oa status in the ScholarIQ index.
What is the DOI of Current and emerging pharmacotherapy for the treatment of adult attention deficit hyperactivity disorder (ADHD)?
The DOI for Current and emerging pharmacotherapy for the treatment of adult attention deficit hyperactivity disorder (ADHD) is on the source record.
What is the PMID of Current and emerging pharmacotherapy for the treatment of adult attention deficit hyperactivity disorder (ADHD)?
The PMID for Current and emerging pharmacotherapy for the treatment of adult attention deficit hyperactivity disorder (ADHD) is on the source record.
What is the OpenAlex record for Current and emerging pharmacotherapy for the treatment of adult attention deficit hyperactivity disorder (ADHD)?
The OpenAlex for Current and emerging pharmacotherapy for the treatment of adult attention deficit hyperactivity disorder (ADHD) is on the source record.